Catalyst Funds Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Catalyst Funds Management's LLY Position: Q2 2026 in Review
Catalyst Funds Management increased its Eli Lilly (LLY) stake by 1,800% in Q2 2026, buying an estimated $36.9M and bringing the position to 38,081 shares worth $45.7M. The position accounts for 2.56% of the portfolio, ranked #6.
Catalyst Funds Management first reported a position in LLY in Q1 2024 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Catalyst Funds Management held 38,081 shares of Eli Lilly worth $45.7M as of Q2 2026.
- Catalyst Funds Management bought 36,077 Eli Lilly shares in Q2 2026, an estimated $36.9M.
- Eli Lilly made up 2.56% of Catalyst Funds Management's portfolio in Q2 2026, its #6 holding.
- Catalyst Funds Management first reported a position in Eli Lilly in Q1 2024 and has held it in 5 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.